We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




All-In-One CLIA Analyzer to Transform Clinical Diagnostics Landscape

By LabMedica International staff writers
Posted on 12 Jul 2023

An automated, compact, and cost-effective CLIA analyzer combines cutting-edge technology with versatile capabilities to provide a wide range of qualitative and quantitative testing options for analytes in human serum, plasma, whole blood, and urine samples. More...

Anbio Biotechnology (Frankfurt, Germany) has launched the Anbio ADL i1910 all-in-one CLIA analyzer that employs a direct chemiluminescence method based on acridinium ester. This ensures accurate and consistent results across a wide range of applications, including hormone detection, myocardial disease screening, infectious disease diagnostics, or tumor-related antigen analysis. The ADL i1910 delivers a powerful performance and fulfills the varied requirements of modern healthcare professionals. It offers an impressive range of 49 developed assays, enabling qualitative as well as quantitative testing of analytes. The ADL i1910 provides a comprehensive immunodiagnostic solution for healthcare providers to access vital information in an efficient manner.

The ADL i1910 significantly enhances laboratory productivity, thanks to its high throughput of up to 120 tests per hour. With its quick turnaround times, healthcare providers can arrive at timely and informed decisions, eventually improving patient care. Its intuitive graphic user interface coupled with a large color touch screen simplifies operation and shortens the learning curve. It user-friendly design makes it easy to use for experienced professionals and new users alike, thus improving overall efficiency. Designed to occupy minimal space, the ADL i1910 has a small footprint in order to optimize valuable space for other necessary lab equipment, making it ideal for laboratories of all sizes. By offering healthcare providers a cost-effective and comprehensive solution, the Anbio ADL i1910 is expected to transform the clinical diagnostics space.

"Anbio is proud to introduce the ADL i1910, a breakthrough CLIA analyzer that revolutionizes clinical diagnostics," said Jack Davis, Chief Business Officer at Anbio. "With its advanced technology, extensive assay menu, and impressive throughput, the ADL i1910 provides healthcare professionals with a reliable and efficient solution for a wide range of diagnostic applications."

Related Links:
Anbio Biotechnology 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Gold Member
Platelet Function Analyzer
PL-12
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Molecular Diagnostics

view channel
Image: Developed and manufactured by Freenome and exclusively commercialized by Abbott, SimpleScreen CRC joins the Cologuard Plus test in Abbott’s screening portfolio, which now spans both stool‑ and blood‑based options (Photo courtesy of Freenome)

Blood-Based Test Broadens Colorectal Cancer Screening Options

Colorectal cancer is the second-leading cause of cancer-related death in the U.S., yet outcomes improve markedly when the disease is detected through routine screening. Despite this, up to 60 million Americans... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.